Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference15 articles.
1. Morning administration of 0.4U/kg/day insulin glargine 300U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100U/mL in type 1 diabetes;Bailey;Diabetes Metab,2017
2. New insulin glargine 300units.mL−1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100units.mL−1;Becker;Diabetes Care,2015
3. A review of the pharmacological properties of insulin degludec and their clinical relevance;Haahr;Clin Pharmacokinet,2014
4. Basal insulin analogues in the management of diabetes mellitus: what progress have we made?;Owens;Diabetes Metab Res Rev,2014
5. Pharmacokinetics and pharmacodynamics of biosimilar insulins: is clamp technology fit for purpose?;Home;Diabetes Care,2015
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献